About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 935635, 2 pages
http://dx.doi.org/10.1155/2013/935635
Editorial

H. pylori Eradication Therapy

1Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital and National Yang-Ming University, Kaohsiung, Taiwan
2Department of Nuclear Medicine, Kaohsiung Veterans General Hospital and National Yang-Ming University, 386 Ta-Chung 1st Road, Kaohsiung 813, Taiwan

Received 8 January 2013; Accepted 8 January 2013

Copyright © 2013 Ping-I Hsu and Nan-Jing Peng. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Chuah, F. W. Tsay, P. I. Hsu, and D. C. Wu, “A new look at anti-Helicobacter pylori therapy,” World Journal of Gastroenterology, vol. 17, no. 35, pp. 3971–3975, 2011. View at Publisher · View at Google Scholar
  2. D. Y. Graham and S. Akiko, “New concepts of resistance in the treatment of Helicobacter pylori infections,” Nature Clinical Practice Gastroenterology & Hepatology, vol. 5, pp. 321–331, 2008. View at Publisher · View at Google Scholar
  3. A. Zullo, V. De Francesco, C. Hassan, S. Morini, and D. Vaira, “The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis,” Gut, vol. 56, no. 10, pp. 1353–1357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Wu, P. I. Hsu, J. Y. Wu et al., “Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection,” Clinical Gastroenterology and Hepatology, vol. 8, no. 1, pp. 36–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. I. Hsu, D. C. Wu, J. Y. Wu, and D. Y. Graham, “Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (Hybrid) therapy for the final 7 days,” Helicobacter, vol. 16, no. 2, pp. 139–145, 2011. View at Publisher · View at Google Scholar · View at Scopus